Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000921895-25-001026·Aptevo Therapeutics Inc.
Schedule 13G ownership disclosure
APTEVO THERAPEUTICS INC
Common Stock, $0.001 par value · CUSIP: 03835L306
Event date: 2025-04-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BIGGER CAPITAL FUND L P
Shares: 200,000.00 · Class: 6.20%
- Bigger Capital Fund GP, LLC
Shares: 200,000.00 · Class: 6.20%
- Bigger Michael
Shares: 200,000.00 · Class: 6.20%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-001026
- Form type
- SCHEDULE 13G
- Filer
- Aptevo Therapeutics Inc.
- CIK
- CIK 1671584
- Filed
- Apr 08, 2025
- Reporting period
- Apr 03, 2025
- Description
- Schedule 13G beneficial ownership